Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | FGTI-2734 |
Synonyms | |
Therapy Description |
FGTI-2734 is a peptidomimetic inhibitor of RAS farnesylation and geranylgeranylation, which results in decreased membrane localization of RAS and downstream signaling, and potentially leads to decreased growth of RAS-mutant tumors (PMID: 31227505). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
FGTI-2734 | RAS Inhibitor (Pan) 12 | FGTI-2734 is a peptidomimetic inhibitor of RAS farnesylation and geranylgeranylation, which results in decreased membrane localization of RAS and downstream signaling, and potentially leads to decreased growth of RAS-mutant tumors (PMID: 31227505). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|